Serstech AB

Stockholm Stock Exchange SERT.ST

Serstech AB Price to Sales Ratio (P/S) on January 14, 2025: 4.82

Serstech AB Price to Sales Ratio (P/S) is 4.82 on January 14, 2025, a 130.94% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Serstech AB 52-week high Price to Sales Ratio (P/S) is 5.81 on July 03, 2024, which is 20.67% above the current Price to Sales Ratio (P/S).
Serstech AB 52-week low Price to Sales Ratio (P/S) is 2.00 on January 25, 2024, which is -58.47% below the current Price to Sales Ratio (P/S).
Serstech AB average Price to Sales Ratio (P/S) for the last 52 weeks is 3.78.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Stockholm Stock Exchange: SERT.ST

Serstech AB

CEO	Mr. Stefan Sandor
IPO Date	Aug. 28, 2013
Location	Sweden
Headquarters	Aldermansgatan 13
Employees	25
Sector	Materials
Industries Chemicals & Advanced Materials Medical Instruments Petrochemicals Pharmaceuticals

Description

Serstech AB provides chemical identification instruments worldwide. It offers the Serstech 100 Indicator, a handheld, small, and light Raman spectrometer for measuring chemicals, such as explosives, narcotics, toxic industrial chemicals, pharmaceuticals, and chemical warfare agents; and ChemDash, a central management software for Serstech devices. The company also provides Serstech Arx and Serstech Arx+ revolutionizing instruments for quick and precise identification of chemical substances; and Serstech's SERS kit that allows for quick identification of low concentrations and narcotics samples. It offers its solutions for explosive, CBRN and hazmat, narcotics, and pharma applications. Serstech AB was incorporated in 2006 and is headquartered in Lund, Sweden.

Key trends

Past 5 years